Abstract
Cell-based assays for the inhibition of viral infections most commonly couple a positive signal (e.g., an increase in fluorescence) to the infection itself and not to its inhibition. When performing drug screens, compounds decreasing the signal are therefore considered as putative inhibitors. However, this approach can cause the selection of many false positives, since, for example, both killing of the host cell and inhibiting viral cell-entry results in the same signal. Using a model system based on murine leukemia virus (MLV) particles pseudotyped with the G-protein of vesicular stomatitis virus (VSV-G), we have developed generic assays coupling a positive readout to the inhibition of viral transduction. Consequently, the system favors drug candidates (and concentrations thereof) that do not harm human cells and significantly decreases the probability for selecting false positives. The assay allows Z-factors of ∼0.9, takes cytotoxic side effects into account and could in theory be adapted for high-throughput screening of inhibitors against further viral species.
Keywords: High throughput screening, antivirals, cell-entry inhibitors, pseudotyped viruses, fluorescence assay
Combinatorial Chemistry & High Throughput Screening
Title: Coupling the Inhibition of Viral Transduction with a Positive Fluorescence Signal
Volume: 13 Issue: 4
Author(s): Jenifer Clausell-Tormos, Andrew D. Griffiths and Christoph A. Merten
Affiliation:
Keywords: High throughput screening, antivirals, cell-entry inhibitors, pseudotyped viruses, fluorescence assay
Abstract: Cell-based assays for the inhibition of viral infections most commonly couple a positive signal (e.g., an increase in fluorescence) to the infection itself and not to its inhibition. When performing drug screens, compounds decreasing the signal are therefore considered as putative inhibitors. However, this approach can cause the selection of many false positives, since, for example, both killing of the host cell and inhibiting viral cell-entry results in the same signal. Using a model system based on murine leukemia virus (MLV) particles pseudotyped with the G-protein of vesicular stomatitis virus (VSV-G), we have developed generic assays coupling a positive readout to the inhibition of viral transduction. Consequently, the system favors drug candidates (and concentrations thereof) that do not harm human cells and significantly decreases the probability for selecting false positives. The assay allows Z-factors of ∼0.9, takes cytotoxic side effects into account and could in theory be adapted for high-throughput screening of inhibitors against further viral species.
Export Options
About this article
Cite this article as:
Clausell-Tormos Jenifer, D. Griffiths Andrew and A. Merten Christoph, Coupling the Inhibition of Viral Transduction with a Positive Fluorescence Signal, Combinatorial Chemistry & High Throughput Screening 2010; 13 (4) . https://dx.doi.org/10.2174/138620710791054312
DOI https://dx.doi.org/10.2174/138620710791054312 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Current Nanoscience Targeting Trail Towards the Clinic
Current Drug Targets In Vivo Application of beta Amyloid Oligomers: A Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches
Current Pharmaceutical Design Probiotics in Female Reproductive Health: Paradigms, Prospects and Challenges
Current Women`s Health Reviews Ellagic Acid Increases Osteocalcin and Alkaline Phosphatase After Tooth Extraction in Nicotinic-Treated Rats
Current Pharmaceutical Design Profiling the Shear Stress of Atherosclerosis; A Genomic View
Current Genomics Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery
Current Pharmaceutical Design Surfactant Protein A - From Genes to Human Lung Diseases
Current Medicinal Chemistry Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors
Current Drug Targets Emerging Approved Treatments for Idiopathic Pulmonary Fibrosis: Some Hope for Patients?
Current Respiratory Medicine Reviews Acute HCV in HIV-Positive Individuals – A Review
Current Pharmaceutical Design Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Mechanism of Action of Flavonoids in Prevention of Inflammation- Associated Skin Cancer
Current Medicinal Chemistry How to Investigate the Vascular Changes in Resistant Hypertension
Current Hypertension Reviews Probiotics in the Prevention of Urogenital Tract Infections. Mechanisms Involved
Current Women`s Health Reviews Obesity Associated Modulation of miRNA and Co-Regulated Target Transcripts in Human Adipose Tissue of Non-Diabetic Subjects
MicroRNA Small and Hungry: MicroRNAs in Micronutrient Homeostasis of Plants
MicroRNA Meet Our Associate Editor
Current Molecular Medicine Terpenoids and Glycolipids from Euphorbiaceae
Mini-Reviews in Medicinal Chemistry Gene Electrotransfer in 3D Reconstructed Human Dermal Tissue
Current Gene Therapy